Skip to main content
OpenTrials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

357 public trials 121 recruiting studies
Refine in advanced search Browse all conditions

NSCLC trial results

Active, Not Recruiting

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

NCT05256290

Conditions
Advanced Lung Carcinoma, Advanced Non-Small Cell Squamous Lung Cancer, Brain Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Huntington Beach Huntington Beach, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT05787587

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Cancer, +44 more
Locations
  • HonorHealth Research Institute Phoenix, Arizona, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib

NCT04764188

Conditions
NSCLC
Locations
  • Clinica Adventista Belgrano Ciudad Autonoma Buenos Aires, Argentina
  • Lifehouse Camperdown, New South Wales, Australia
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
View all 116 locations
View Trial Details
Active, Not Recruiting

Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

NCT05059522

Conditions
Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +17 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • The Regents of the University of California Los Angeles, California, United States
View all 71 locations
View Trial Details
Active, Not Recruiting

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

NCT05798663

Conditions
NSCLC
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Kaiser Permanente Oakland Medical Center Oakland, California, United States
  • Kaiser Permanente Roseville Medical Center Roseville, California, United States
  • Kaiser Permanente San Francisco Medical Center San Francisco, California, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

NCT06246110

Conditions
NSCLC, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Southern Cancer Care Daphne, Alabama, United States
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • California Cancer Care Associates for Research & Excellence Fresno, California, United States
  • California Research Institute Los Angeles, California, United States
View all 38 locations
View Trial Details

Related conditions